Baxter International Second Quarter 2016 Financial Results
Get Alerts BAX Hot Sheet
Join SI Premium – FREE
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its second quarter 2016 financial results on Tuesday, July 26, 2016, at 7:30 a.m. central time.
To access the call, dial 844.886.1929 (domestic) or 225.239.4663 (international). Please dial into the call at least ten minutes prior to the start for the operator to connect you. The conference ID is 40547466.
This call is also being webcast by Nasdaq OMX and can be accessed at Baxter’s website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission.
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160627006073/en/
Baxter International
Media Contact
Deborah Spak,
224.948.2349
or
Investor Contact
Clare Trachtman,
224.948.3085
Source: Baxter International
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
- World Kinect Corporation (WKC) Misses Q1 EPS by 2c, Misses on Revenue
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!